rs11520696 - DGKB - GTF3AP5
Magnitude 2.2 · 1 study on file
Reported associations
-
Genetics of 35 blood and urine biomarkers in the UK Biobank - Unknown journal (n.d.) · Unknown authors · PubMed 33462484
ABSTRACT: Clinical laboratory tests are a critical component of the continuum of care. We evaluate the genetic basis of 35 blood and urine laboratory measurements in the UK Biobank (n=363,228 individuals). We identify 1,857 loci associated with at least one trait, containing 3,374 fine-mapped associations, and additional sets of large-effect (> 0.1 sd) protein-altering, HLA, and copy-number variant associations. Through Mendelian Randomization analysis, we discover 51 causal relationships, including previously known agonistic effects of urate on gout and cystatin C on stroke. Finally, we develop polygenic risk scores for each biomarker and built 'multi-PRS' models for diseases using 35 PRSs simultaneously, which improved chronic kidney disease, type 2 diabetes, gout, and alcoholic cirr
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Diet
-
limit refined carbohydrates and added sugars Moderate
DGKB is involved in glucose signaling; refined carbohydrates elevate glucose spikes, particularly important for genetically predisposed individuals
reduce refined grains; choose whole grains and legumes; minimize sugary beverages and desserts
Discuss with your doctor
-
personalized glucose management and prevention Moderate
DGKB variant affects glucose regulation; physician assessment determines risk level and appropriate interventions based on full clinical picture
Exercise
-
regular physical activity for glucose regulation Moderate
Exercise improves insulin sensitivity and glucose utilization, counteracting genetic predisposition to elevated blood glucose
150 minutes moderate aerobic activity weekly plus 2-3 resistance training sessions
Screening
-
baseline and periodic glucose testing Moderate
DGKB variant associated with elevated blood glucose levels; screening identifies risk and enables early intervention
baseline fasting glucose and HbA1c; repeat annually or per physician recommendation